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Figure S1. Analysis of the Esrrb LBD requirement in ESCs. (A) Diagram 
indicating Flag-tagged wild-type (Wt) and Esrrb deletion mutants lacking either the 
LBD (ΔLBD) or AF-1 (ΔAF-1) domain. (B) Expression of Flag-tagged wild-type (Wt) 
Esrrb or deletion mutants in ESCs. (C) Luciferase assays for Esrrb-bound targets. 
ESCs were transfected with the indicated ERRE-containing reporter plus either 
control (shScrambled) or shRNA to endogenous Esrrb (shEsrrb), and with or without 
RNAi-resistant Esrrb rescue constructs as depicted in (A). (D) Indicated morphology 
and Alkaline phosphatase (AP) staining for colonies scored in self-renewal assays, 
categorized as undifferentiated (>85% AP-positive), mixed (15-85% AP-positive) or 
differentiated (<15% AP-positive). (E) Structural basis for diethylstilbestrol (DES)-
induced ERR inactivation. Crystal structure of the ERRγ LBD complexed with DES 
(green), superimposed upon the apoLBD (yellow). DES binding induces a rotational 
shift in helix 11 (H11), leading to steric clashing of F435 (corresponding to F310 in 
Esrrb) with H12 in the agonist position. Adapted with permission from (Greschik et al. 
2004). (F) The activity of luciferase reporters from (C) was measured in ESCs 
following 24 hours treatment with increasing doses of DES (from 3-12.5µM). No 
significant cell toxicity was noticed within this range of DES concentrations. (G-H) AP 
staining of ESCs following treatment with DES for 4 days. Colonies were quantified 
as in Figure S1D. Data are mean +/- SEM of three independent experiments. 
Statistical significance of the difference between numbers of undifferentiated colonies 
in samples compared to ethanol-treated (0µM DES) ESCs was calculated using 
Student’s t-test; ** denotes P-values <0.01. 
Figure S2. Analysis of PRC and Ncoa3 as putative Esrrb coactivators in ESCs. 
(A) Expression profiling of members of the PGC-1 coactivator family in ESCs, as 
assessed by qRT-PCR and normalised to two housekeeping genes. Expression 
levels in brown adipose (IMBAT) cells with and without CL-316,243, a β3-AR ligand 
and inducer of PGC-1α expression (Debevec et al. 2007), are shown as controls. (B) 
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shRNA-mediated depletion of PRC in ESCs 48 hours following transfection. Data for 
(A-B) are mean +/- SEM of three independent biological replicates. ** denotes P-
values <0.01 as calculated using Student’s t-test. (C) Activity of Enhancer-Luc 
reporters in ESCs following cotransfection with shScrambled (control), shEsrrb or 
shPRC. (D-E) AP staining and quantification of ESCs plated at low density then 
transfected with shScrambled, shPRC or shEsrrb and selected with Puromycin for 5 
days. Data are mean +/- SEM of three independent experiments. Student’s t-test of 
the difference in undifferentiated colonies in shPRC or shEsrrb compared to 
shScrambled is shown; *** P-values <0.001. (F) Co-immunoprecipitation (Co-IP) of 
ectopically expressed Flag-Esrrb Wt or point-mutant forms and Ncoa3 in COS-1 
cells. (G) Interaction between endogenous Esrrb and Ncoa3 proteins in ESC 
extracts, as assessed by Co-IP and western blot. At least two experiments were 
performed with similar results. (H) Depletion of Ncoa3 protein 48 hours after 
transfection with siControl or siNcoa3 oligos. Tubulin is shown as a loading control. 
(I) Luciferase assays assessing the ability of Wt Esrrb to rescue reporter activity with 
or without simultaneous Ncoa3 knockdown. Three experiments were performed with 
similar results.  
Figure S3. Crosstalk between Ncoa3, Esrrb, Oct4 and Nanog in ESCs. (A) 
Western blot for the indicated proteins in ZHBTc4 ESCs (Niwa et al. 2000) treated 
with 1µg/mL Doxyclicline (Dox) for 24 hours to delete Oct4. (B) ChIP assays in 
ZHBTc4 cells after 24 hours with or without Dox treatment, expressed relative to 
input. Enrichment in control cells for each individual experiment is set at 100%. Data 
are mean +/- SD of at least two independent experiments. Dotted lines indicate 
background enrichment by control IgGs. (C) Western blot in RCNβHB ESCs 
(Chambers et al. 2007), treated with 1µM Tamoxifen (OHT) for 24 hours to delete 
Nanog. (D) ChIP in RCNβHB ESCs performed after 24 hours with or without OHT 
treatment. Data are mean +/- SD of at least three independent experiments and are 
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displayed as in (B). (E-H) Co-IP assays to determine whether Ncoa3 interacts with 
Oct4 and Nanog. ESC lysates were immunoprecipitated with (E) anti-Oct4 or (F) anti-
Ncoa3 antibodies, and immunoblotted for Esrrb (top panels) and either Ncoa3 or 
Oct4 respectively (bottom panels). Immunoblotting for Esrrb is shown as a positive 
control for these Co-IPs.  (G) ESCs were immunoprecipitated with anti-Nanog 
antibodies, and immunoblotted for Oct4 or Ncoa3; immunoblotting for Oct4 in the 
same experiment is used as a positive control.  (H) Cell lysates from COS-1 cells 
transiently cotransfected with either Ncoa3 and Flag-Esrrb (top) or Ncoa3 and Nanog 
(bottom) expression vectors were immunoprecipitated using anti-Ncoa3 antibodies 
(BDBiosciences, mouse monoclonal #611105), and immunoblotted for Flag-Esrrb 
(positive control) or Nanog.  
Figure S4. Ectopic expression of Ncoa3 enhances ESC self-renewal. (A) Self-
renewal assay of stable ESC lines expressing CAG-Control, CAG-Ncoa3, or CAG-
Nanog vectors. Pooled clones once generated were re-plated at clonal density, and 
then maintained in absence or presence of LIF as indicated for 5 days. Cells were 
fixed, stained for AP and counted as in Figure S1D. Data are mean +/- SEM of three 
independent experiments. Statistical significance of the difference in undifferentiated 
colonies compared to ESC CAG-Control was calculated using Student’s t-test; * P-
values <0.05, ** P-values <0.01. Nanog-overexpressing ESCs have been previously 
shown to support LIF-independent self-renewal (Chambers et al. 2003; Mitsui et al. 
2003) and were used as a positive control. (B) Quantitative expression analysis of 
ESC-related genes in stable ESC lines. Data are mean +/- SEM of three independent 
experiments. (C) Expression profiles of Ncoa3, Esrrb, and two early differentiation 
markers (Fgf5 and Gata6) in ESC CAG-Control or ESC CAG-Ncoa3 cells during 
embryoid body (EB)-mediated differentiation. 
Figure S5. Ncoa3 is required for somatic cell reprogramming. (A) Microarray 
expression data (Mikkelsen et al. 2008) showing upregulation of indicated 
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endogenous factors during reprogramming. (B) Immunofluorescence staining for 
indicated proteins and GFP in iPSC clone 1. Scale bars, 50µm. (C) Expression of 
Ncoa1, Ncoa2 and Ncoa3 in MEFs infected with shScrambled or shNcoa3 #2 
measured 3 days after lentiviral transduction, as assessed by qRT-PCR and 
normalised to two housekeeping genes. Note that the expression of Ncoa3 is over 
10-fold lower than in ESCs as shown in Fig. 2A. Data are mean +/- SEM of three 
experiments. Student’s t-test; * P-values <0.05. ** P-values <0.01. (D) Schematic 
depicting Ncoa3 knockdown and reprogramming experiments performed in Oct4GFP 
and p53-/- MEFs. (E) Quantification of BrdU-positive cells in shScrambled or shNcoa3 
infected MEFs following a 16-hour pulse-labelling period, performed 3 days after 
lentiviral infection. Micrographs show representative BrdU-staining (green) and DAPI 
(blue) in both cell types. At least 350 cells were counted per sample; scale bars, 
25µm. (F) Quantification of nuclei staining positive for cleaved Caspase-3, a marker 
of apoptosis, in MEFs 3 days after infection with lentiviruses. Data are expressed as 
numbers of apoptotic cells per 500 cells counted. Micrograph shows example 
staining for Caspase-3 (red) overlaid with DAPI (blue) upon Staurosporine treatment; 
scale bar, 50µm. Results for (E-F) are mean +/- SEM of three independent infections. 
Figure S6. Ncoa3 ChIP-seq in ESCs. (A) Genome browser screenshots showing 
binding of Esrrb, Nanog, Ncoa3, Oct4 and Sox2 to the indicated genomic loci. (B) 
GREAT Gene Ontology analysis of significantly enriched phenotypes associated with 
Ncoa3-Esrrb co-bound targets.  
Figure S7. DNA sequence motifs represented at Ncoa3 ChIP-seq peaks. DNA 
sequences found by MEME with associated E-values, generated from the top 500 
sites (100bp wide) of Ncoa3 ChIP-seq peaks. The four top significant motifs (E-
values <0.01) are shown. MEME provides an E-value of the found motif, which is a 
product of P-values. See http://www.sdsc.edu/~tbailey/MEME-protocol-
draft2/protocols.html. 
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Figure S8. Genome-wide analysis of Ncoa3 targets in ESCs. (A) Validation of 
Ncoa3 microarray. cDNA generated from the same samples used for the Ncoa3 
knockdown microarray was analysed via qRT-PCR for expression changes to the 
indicated genes. Candidates from class Ia and Ib Ncoa3-bound targets were selected 
based on their identification in Ncoa3 class Ia or Ib GO analysis, and significant 
downregulation (P<0.05) upon Esrrb knockdown, as determined by microarray (Feng 
et al. 2009). Data were normalised to two housekeeping genes and expressed as 
mean +/- SEM of three biological replicates. Significant expression changes were 
identified by Student’s t-test, * P-values <0.05, ** P-values <0.01. (B) Spatial 
heatmap for Class III Ncoa3-bound genes, grouped into two subclusters according to 
the absence (IIIa) or the presence (IIIb) of H3K4me1. No Polycomb occupancy was 
detected at either subcluster, represented by Suz12 and Ezh12. The nearest genes 
within 100Kbp of Ncoa3 peaks in each subcluster were then analysed for significant 
fold-change (>1.5) upon Ncoa3 knockdown. The proportion of those genes that are 
either upregulated (red) or downregulated (green) for IIIa and IIIb are displayed as a 
pie chart. (C) Western blot showing Ncoa3 knockdown by siNcoa3 in lysates used for 
Co-IP experiments. (D-E) Co-IP of Esrrb immunoblotted for (D) Esrrb and (E) Oct4 in 
ESCs treated for 48 hours with siControl or siNcoa3 oligos. At least two experiments 
were performed with similar results. 	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The top motifs found by meme with E-value in top 500 sites (100 bp wide) of Ncoa3. 
Meme provides E-value of the found motif, which is product of P-values. 
See  http://www.sdsc.edu/~tbailey/MEME-protocol-draft2/protocols.html 
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Supplemental Table S6. shRNA, primer and probe sequences 
shRNA name shRNA sequence / reference 
pLKO.1 shScrambled CAACAAGATGAAGAGCACCAA 
pLKO.1 shNcoa3 #1 CGGCAGGCACTTGAAATGAAA 
pLKO.1 shNcoa3 #2 GCCGATTACAGTGCCACTTTA 
pLKO.1 shPRC GAGAGCTGCTAGTGTGGAAA 
pSUPER.shScrambled GACGTTAGCAATCGAGCTC 
pSUPER.puro-shGFP (Loh et al. 2006) 
pSUPER.puro-shEsrrb (Loh et al. 2006) 
 
qPCR primer 
name 
Primer sequence (5’3’) 
Actin Fw: CGAGGCCCAGAGCAAGAG Rv: CGTCCCAGTTGGTAACAATGC 
B2m Fw: TGGTGCTTGTCTCACTGACC Rv: TATGTTCGGCTTCCCATTCT 
Ccnd3 Fw: ACCTTTGCGATGTATCCTCC Rv: TTCGATCTGTTCCTGGCAGG 
Cdx2 Fw: TCAACCTCGCCACAACCTTCCC Rv: TGGCTCAGCCTGGGATTGCT	  
Esrrb Fw: GCACCTGGGCTCTAGTTGC Rv: TACAGTCCTCGTAGCTCTTGC	  
Epha4 Fw: AGATGTGATCAAAGCCATCG Rv: TCTAACAAGGCTGTGTTTGG 
Fancc Fw: TGAGAGTCCCAGTGGAGACC Rv: GTGATCTGTACAAGGTCTGG 
Fgf5 Fw: TGTGTCTCAGGGGATTGTAGG Rv: AGCTGTTTTCTTGGAATCTCTC	  
Gadd45a Fw: AAGTGCTCAGCAAGGCTCGG Rv: CACGGATGAGGGTGAAATGG 
Gata3 Fw: AGTCGAGGCCCAAGGCACGA Rv: GCTGCCGACAGCCTTCGCTT	  
Gata6 Fw: GAGCTGGTGCTACCAAGAGG Rv: TGCAAAAGCCCATCTCTTCT	  
Inhbb Fw: GCGTCTCCGAGATCATCAGC Rv: CTTGACCCGTACCTTCCTCC 
Hsf2 Fw: TCAACATGTGTCAGAAGAGG Rv: GGCACAACTTCTGACGATGC 
Klf2 Fw: CTTGCAGCTACACCAACTGC Rv: TCCTTCCCAGTTGCAATGAT 
Klf4 Fw: GTGCCCCGACTAACCGTTG Rv: GTCGTTGAACTCCTCGGTCT 
Klf5 Fw: GGATCTGGAGAAGCGACGTA Rv: TGAGTCCTCAGGTGAGCTTTT 
L19 Fw: TGATCTGCTGACGGAGTTG Rv: GGAAAAGAAGGTCTGGTTGGA	  
Mixl1 Fw: GACAGACCATGTACCCAGAC Rv: GCTTCAAACACCTAGCTTCAG	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Nanog Fw: CTTACAAGGGTCTGCTACTGA Rv: TCTGCTTCCTGGCAAGGACC	  
Ncoa1 Fw: AGATGGAAACCAGGTCAGTAAGA Rv: TCCAGAGTGATCGAATCTGCC	  
Ncoa2 Fw: ATCTCGAAAATTGCTGACCCTG Rv: TGGCAACACAAAGAGACGCA	  
Ncoa3 Fw: TCTCAGCGACATCGACAACTT Rv: GCCTGTAGTAAAAGCGGTCCTA	  
Oct4 Fw: CGTGGAGACTTTGCAGCCTG Rv: GCTTGGCAAACTGTTCTAGCTCCT 
PGC-1α Fw: CCCTGCCATTGTTAAGACC Rv: TGCTGCTGTTCCTGTTTTC 
PGC-1β Fw: CCACAGCCCACTTCCAGAGA Rv: CTTGCCAAGAGAGTCGCTTTGT	  
Pou5f1 Fw: CGTGGAGACTTTGCAGCCTG Rv: GCTTGGCAAACTGTTCTAGCTCCT	  
Prdm5 Fw: GCATGTAAAGCCTTGTTCCG Rv: GTGTGTCTTCTTATGACTCC 
Prdm14 Fw: GCATCCTGGTTCCCACAGAG Rv: CTGCAGAACACGCCAAAGTG 
PRC Fw: GGCCCAGCACAGGAGTAGTC Rv: CAAGAAAGGAGGCGAGAGAA	  
Sall3 Fw: AGAAGCCCTTTGGCTGCACC Rv: ATCTCAGAGAACTTGAGAGC 
Smarcad1 Fw: CTCTTGTCAACTAAAGCTGG Rv: CTCTTCAATAGTTCCTTGGC 
Sox2 Fw: AAAACCACCAATCCCATCCA Rv: CGAAGCGCCTAACGTACCAC	  
T Fw: GCTTCAAGGAGCTAACTAACGAG Rv: CCAGCAAGAAAGAGTACATGGC	  
Tbx3 Fw: GAACCTACCTGTTCCCGGAAA Rv: CAATGCCCAATGTCTCGAAAAC 
Tcfap2c Fw: GGCTGACTATTTAACGAGACC Rv: CAGTTTTGTATGTTCGGCTCC 
Tcfcp2l1 Fw: GAGTCTTGTTTTATCCTCAGC Rv: ACAGCAGCTGACAGTGGTGC 
Tgif1 Fw: CCCTCAGAGCAAGAGAAAGC Rv: GGAAATCGTGAACTGATTTGG 
Trim24 Fw: AAGCCTGAAGACTTTGTAGC Rv: ACAGTCTTCTGCTTCATGCC 
Zfp42 Fw: CTCCTAGCCGCCTAGATTTCCA Rv: CGTGTCCCAGCTCTTAGTCCATT 
Zfp57 Fw: GTCAGAAACCTTCAAGAACC Rv: CTGGTGATTAAAGAGGAAGG 
 
ChIP primer name Primer sequence (5’3’) 
Esrrb-ERRE Fw: ATAGAACCCACAACGTGACC Rv: AGTGGTCAAAGCCACTCTGC	  
Klf4-ERRE Fw: TAGATAGCTAAAGCAGGGGG Rv: TGTCTTTGCAACTGGCCTCC	  
Nanog-ERRE Fw: TCGCCAGGGTCTGGAGGTGC Rv: TCCCACCTGCAGGGTCCACC 
Sox2-ERRE Fw: ACTTCTCAACCTCACTGACC Rv: TGGAGTTTGGGAAATTCGACC	  
Intergenic-Chr.8 Fw: AAGGGGCCTCTGCTTAAAA Rv: AGAGCTCCATGGCAGGTAGA	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DNA Probe Sequence (ERREs are underlined with mutated bases in lowercase; 
Oct-Sox element is in bold) 
Esrrb-Wt CCTGCAGCATCCCTGCTTCAAGGTCAACTGAAAAGCCTGGGCTCCAGCAG 
Esrrb-mut CCTGCAGCATCCCTGCTTCAAaaTCAACTGAAAAGCCTGGGCTCCAGCAG 
Klf4-Wt TGCTTTTGACCTTGGAGGCCCCAGGGCACTGTTATTTTCC 
Klf4-mut TGCTTTTGAttTTGGAGGCCCCAaaGCACTGTTATTTTCC 
Nanog-Wt CCAGTCTGGGTCACCTTACAGCTTCTTTTGCATTACAATGTCCATG 
Nanog-mut CCAGTCTGaacCACCTTACAGCTTCTTTTGCATTACAATGTCCATG 
Sox2-Wt CCACCACTTGCAAGGGCAGGCAGAGGTCGAATTTCCCAAA 
Sox2-mut CCACCACTTGCAAaaGCAGGCAGAaaTCGAATTTCCCAAA 
 
Supplemental Material and Methods 
Cell Culture. Mouse E14Tg2A ESCs were cultured on 0.1% gelatin-coated plates 
and maintained in GMEM supplemented with 10% fetal calf serum (FCS), MEM non-
essential amino acids, beta-mercaptoethanol, L-glutamine, sodium pyruvate, sodium 
bicarbonate, penicillin/streptomycin and LIF. Mouse ZHBTc4 (Niwa et al. 2000) and 
RCNβHB (Chambers et al. 2007) ESCs have been previously described. iPSCs were 
generated and maintained in DMEM supplemented with 15% KnockOut serum 
replacer (GIBCO), beta-mercaptoethanol, L-glutamine, MEM non-essential amino 
acids, penicillin-streptomycin and LIF. MEF, COS-1 and 293T cells were cultured in 
DMEM supplemented with 10% FBS, glutamine and penicillin/streptomycin. PlatE 
cells were as 293T, supplemented with 1µg/ml Puromycin and 10µg/ml Blasticidin 
(Sigma). Where used, diethylstilbestrol (DES, Sigma) or vehicle (ethanol) control was 
added to the culture medium at the indicated concentration.  
Differentiation experiments. For embryoid body (EB)-mediated differentiation, 
ESCs were trypsinized to single-cell suspension and 1x105 cells plated per well in 
ESC media minus LIF on ultra low attachment 6-well plates (Corning). For retinoid-
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mediated differentiation, cells were plated in normal ESC culture conditions, and next 
day media replaced with ESC media minus LIF containing 1µM all-trans retinoic acid 
(Sigma), and cultured for the indicated number of days. 
RNAi knockdown. pLKO.1 shRNA vectors targeting Ncoa3, or a scrambled control, 
were purchased from Sigma and used in ESC and iPSC assays. OnTarget Plus 
siNcoa3 pool and siControl (Dharmacon) were used in luciferase assays. 
pSuper.shEsrrb has been described previously (Loh et al. 2006). See Table S6 for 
shRNA sequences. For Ncoa3 knockdown in ESCs, E14 were plated in 6-well plates 
and 5 hours later were transfected with 1µg linear pLKO.1 vectors using 
Lipofectamine 2000 (Invitrogen), according to the manufacturer’s protocol. 1µg/ml 
Puromycin (Sigma) was added 24 hours post transfection and cells harvested after 
96 hours Puromycin selection. For Ncoa3 knockdown in MEFs, lentiviruses 
harbouring pLKO.1 vectors were produced in 293T cells, concentrated, and viral titer 
calculated according to GFP fluorescence using pLKO.3G (Addgene). MEFs were 
seeded in 12-well plates and after 5 hours infections performed. Cells were 
incubated with viruses for 24 hours before replacement with normal MEF media.  
Self-renewal assays. To generate cell lines overexpressing indicated constructs, 
E14 ESCs were transfected with the relevant linearized vectors using standard 
Lipofectamine 2000 protocols (Invitrogen). 24 hours following transfection, 
Puromycin (1µg/ml, Sigma; pPyCAG-IP) or Zeocin (300µg/ml, Invitrogen; 
pCDNA4/TO) was added. Cells were maintained under selection for 8-9 days, then 
colonies pooled and cells re-plated at clonal density. The next day, media was 
exchanged for media minus LIF where indicated and cells maintained for 5 days 
before fixation and staining for AP using standard protocols (Sigma).  
RNA extraction, reverse transcription and real-time quantitative PCR. RNA was 
extracted using the RNeasy mini kit and treated on-column with DNase I (Qiagen), 
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then used to generate cDNA according to the Superscript II RT-PCR Kit (Invitrogen). 
Gene expression analysis was performed via quantitative PCR using SYBR Green 
Master Mix (Sigma) on an ABI StepOne or 7900HT Real-Time PCR machine. 
Expression levels were normalized to two housekeeping genes (Actin, L19 or B2m). 
See Supplemental Table S6 for a full list of primer sequences used.  
Plasmids. Esrrb, Klf4 and Sox2 luciferase reporters have been described previously 
(Feng et al. 2009), and Nanog-Luc (Rodda et al. 2005). Nanog-Luc and pSG5.Flag-
mEsrrb were kindly provided by P. Robson and V. Cavailles, respectively. Esrrb 
deletion mutants were generated by substituting full length Esrrb for truncated 
versions (99-433aa; ΔAF-1 or 1-203aa: ΔLBD) inserted into BamHI and XbaI sites 
downstream of the Flag-tag. Esrrb point-mutants (C120G/C123G: DBD-mutant, 
K259A: AF2-mut1, L424A/F425A: AF2-mut2) were generated using the QuikChange 
XL Mutagenesis kit (Stratagene). For stable overexpression in ESCs, cDNAs 
encoding Esrrb or Ncoa3 were cloned into XhoI and PacI sites in the pPyCAGIP 
vector (Chambers et al. 2003), and into KpnI/NotI sites in pCDNA4/TO (Ncoa3). Oct4 
and Sox2 were subcloned from pMXs into BstXI sites in pCDNA4/TO. Constructs 
were verified by sequencing and western blot.  
Western blotting. For whole cell extracts, cells were scraped in ice-cold RIPA 
buffer, subjected to two freeze-thaw cycles then incubated with rotation for 20 min, 
4°C. Protein concentration was determined using the BCA assay kit (Pierce) and 20-
30µg total protein was prepared in SDS buffer and separated on 4-12% pre-cast 
NuPAGE Bis-Tris gels (Invitrogen) then transferred to PVDF membranes (GE 
Healthcare). Membranes were probed with primary antibodies in 5% milk-TBST, 
followed by the appropriate HRP-conjugated secondary antibodies (Dako).  
Immunofluorescence. Cells were seeded on gelatin-coated glass coverslips and 
fixed for immunofluorescence after the indicated number of days with 4% 
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paraformaldehyde, 10 min. Slides were washed in PBS, blocked and permeabilized 
at room temperature before incubating overnight at 4°C with the relevant primary 
antibodies. Next day, secondary antibodies conjugated to Alexa-fluor 488nm, 568nm 
or 633nm (Invitrogen) were added and incubated for 1 hour at room temperature. 
Coverslips were washed and mounted in Vectorshield containing DAPI and slides 
visualised using a Leica SP5 confocal microscope.  
BrdU and Caspase-3 staining. BrdU incorporation and staining was carried out as 
previously described (Banito et al. 2009), 3 days after lentiviral infection. MEFs were 
fixed in 4% PFA and staining for cleaved Caspase-3 carried out as for other 
immunofluorescence experiments. Uninfected MEFs treated with 10-100nM 
staurosporine for 16 hours to induce apoptosis were stained for Caspase-3 alongside 
shRNA-transduced cells as a positive control. 
ChIP-seq data processing. ChIP-seq was performed on chromatin prepared from 
mouse ESCs, using an Illumina Genome Analyzer II. The sequenced tags of the 
Ncoa3 ChIP and control samples were aligned to mouse genome (version mm8). 
Peak detection was performed using MACS with options (P-value=1.0E-5, 
gsize=1.87E9, mfold=10,30). The peaks for Oct4, Sox2, Esrrb and CTCF were taken 
from (Chen et al. 2008). Peaks for Nr5a2 were taken from (Heng et al., 2010). In 
order to compare peak overlaps of Esrrb, Oct4, Sox2 and CTCF within 200bp, 
binomial tests were used to assess the significance of the observed intersections. 
Significantly represented DNA motifs found by MEME were generated from the top 
500 sites (100bp) from Ncoa3 ChIP-seq peaks.  
Spatial heatmap. For clustering multiple ChIP-seq signals at given bed file, each 
ChIP-seq data was first arranged in form of tag-count in 200bp bins. Here the bed file 
contains centres of Ncoa3 peaks. Log of the tag-count signal was used to make the 
heatmap plot and clustering. For each ChIP-seq data, the maximum value within 2kb 
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around each given position in the bed file was taken in one column of a 2-
dimensional (n x k) matrix, where n is the number of positions in bed file and k is the 
number of ChIP-seq libraries. This 2D matrix was provided as input for the K-means 
clustering program in Matlab to generate classes for each position. After achieving 
classes, one 2D matrix (n x 2w) was for made for each tag-count data taking values 
with in w bins around each position as a row of the matrix. Each 2D matrix 
corresponding to a ChIP-seq library was then sub-plotted using the imagesc function 
in Matlab.  
Gene ontology. For finding the enrichment of terms for genes near selected peaks, 
GREAT (McLean et al. 2010) was used such that the whole genome was considered 
as background (binomial mode). Only the terms with binomial Q-value better than 
0.05 were selected from output. Top results are reported here such that multiple 
redundant terms with same genes are represented by only one term with highest 
binomial P-value. 
Microarray. RNA was obtained from E14 ESCs transfected with shScrambled or 
shNcoa3 #2 and harvested 3 days after Puromycin selection. Three biological 
replicates per knockdown condition were isolated. Reverse transcription, 
amplification, and cRNA biotinylation were performed using Illumina TotalPrep RNA 
Amplification Kit according to the manufacturer's instructions. Biotinylated cRNA was 
then hybridized to an Illumina Mouse WG-6 v2.0 expression beadchip, and analysed 
as previously described (Feng et al. 2009). Results obtained were rank invariant 
normalised, and the correlation between Ncoa3 knockdown and Esrrb knockdown (3 
days after Puromycin selection) was calculated using previously published 
microarray data (Feng et al. 2009). 
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